Corona Remedies IPO Allotment News Today: Investor Response & Market Insights

The Corona Remedies IPO is garnering significant attention in India’s financial markets thanks to its massive subscription rate. Having raised ₹655.37 crore, the offering has captivated investors with a 137.04x subscription. As the allotment of shares finalizes today, market observers are eager to see the potential impact on stock performance ahead of its December 15 listing. This report provides insights into the IPO subscription status, investor responses, and projected market movements.